期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 8, 期 2, 页码 293-303出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.8.2.293
关键词
chemotherapy; malignant pleural mesothelioma; multimodality therapy; radiotherapy; surgery
类别
Malignant pleural mesothelioma (MPM) is a rare but lethal cancer associated with asbestos exposure. Worldwide, the incidence of MPM is expected to increase over the next 20 years. The molecular and genetic profiling of MPM tumors and patients, and improved understanding of the pathogenesis of MPM may lead to novel diagnostic, preventative and therapeutic strategies. Treatment options for MPM remain limited and no consensus exists at this time. Multimodality therapy that combines surgery, chemotherapy and radiation offers the best chance for long-term survival in select patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据